Response to Regulatory Request with Subsequent Full Signal Assessment - ProPharma
Responding to urgent regulatory safety requests requires balancing speed, scientific rigor, and global compliance. When concerns emerged regarding a potential neurotoxicity signal, the client needed to rapidly evaluate safety data, assess broader class-wide implications, and determine appropriate labeling updates across multiple territories. ProPharma partnered closely with the client to provide pharmacovigilance expertise, coordinate cross-functional stakeholders, and deliver a comprehensive signal assessment within compressed regulatory timelines. This case study explores how a structured pharmacovigilance and signal assessment strategy enabled comprehensive analysis of safety data from diverse sources, supported timely regulatory responses, and strengthened global labeling and risk evaluation processes for related products.
Related Resources
The Cost of Poor Project Management
Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...
Successfully Passing MHRA Inspections for Overseas Manufacturing Sites
ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...
Navigating the Generic Drug Application and Approval Process
Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...